Cite
HARVARD Citation
Penson, R. et al. (n.d.). Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240). Lancet oncology. 16 (3), pp. 301-311. [Online].